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Abstract
Genomic instability is a major hallmark of cancer. To maintain genomic integrity, cells are equipped with dedicated sensors
to monitor DNA repair or to force damaged cells into death programs. The tumor suppressor p53 is central in this process.
Here, we report that the ubiquitous transcription factor Upstream Stimulatory factor 1 (USF1) coordinates p53 function in
making proper cell fate decisions. USF1 stabilizes the p53 protein and promotes a transient cell cycle arrest, in the presence
of DNA damage. Thus, cell proliferation is maintained inappropriately in Usf1 KO mice and in USF1-deficient melanoma cells
challenged by genotoxic stress. We further demonstrate that the loss of USF1 compromises p53 stability by enhancing p53-
MDM2 complex formation and MDM2-mediated degradation of p53. In USF1-deficient cells, the level of p53 can be restored
by the re-expression of full-length USF1 protein similarly to what is observed using Nutlin-3, a specific inhibitor that
prevents p53-MDM2 interaction. Consistent with a new function for USF1, a USF1 truncated protein lacking its DNA-binding
and transactivation domains can also restore the induction and activity of p53. These findings establish that p53 function
requires the ubiquitous stress sensor USF1 for appropriate cell fate decisions in response to DNA-damage. They underscore
the new role of USF1 and give new clues of how p53 loss of function can occur in any cell type. Finally, these findings are of
clinical relevance because they provide new therapeutic prospects in stabilizing and reactivating the p53 pathway.
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Introduction
Genomic instability is a central hallmark of cancer, where DNA
damaging agents play an important role [1–2]. The transforma-
tion of normal cells into cancer cells requires the succession of
several genetics alterations within the genome that alter key
physiological regulatory processes.
In DNA-damaged eukaryotic cells, genome integrity is main-
tained by an immediate and inducible protective program. This
program requires dedicated sensors that drive and regulate the
cellular response, by monitoring DNA-repair and if required by
forcing damaged-cells into cell death pathways [3]. When these
sensors are compromised, sensitivity to mutagenic agents is increased
and the mutation rate speeds up, allowing tumor development. The
extent of DNA lesions and the capacity of dedicated sensors to direct
a proper response are thus determining parameters of cell fate.
To date, the tumor suppressor p53 is the most important sensor
[4], being a central and early regulator of the DNA-damage
response. Upon recognition of DNA damage, p53 induces a
transient growth arrest by holding the cell cycle at the G1/S
regulation point. p53 acts through activating the expression of the
cell-cycle arrest gene CDKN1A (p21) [5,6,7], allowing DNA repair
and thereby preventing the development of cancer. This p53-
dependent transient cell cycle arrest is thus a decisive step in cell
fate that requires the stabilization of p53 protein. Indeed, in the
absence of cellular stress, p53 is maintained at low steady-state
levels by the dynamic p53-MDM2 feedback loop [8]. In response
to DNA-damage signaling, the p53 protein undergoes extensive
post-translational modifications including phosphorylation by
DNAPK, ATM and ATR, all members of the PI3K family [9].
These modifications nucleate subsequent changes in the repertoire
of proteins interacting with p53 and in particular abolish the p53-
MDM2 interaction [10]. This results in the immediate increase in
p53 levels and transcriptional activity, thereby directing cell fate
decisions [11,12,13].
The Upstream Stimulatory Factor 1 (USF1) is an ubiquitous
transcription factor of the basic-helix-loop-helix leucine-zipper
(bHLH-LZ) family that operates as a stress sensor. USF1 is a direct
target of the p38 stress-activated kinase and genetic studies
demonstrate that USF1 is a transcriptional rheostat for the stress
response [14,15,16]. In response to UV-radiation, a physiological
source of direct DNA-damage, known as the major risk factor for
skin cancers [17,18,19,20], USF1 regulates the expression of
pigmentation genes [15], and genes of the nucleotide excision
repair pathway (NER) [21]. This protective function of USF1
is important since the repair of DNA damage is central to the
maintenance of genome stability.
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The USF1 and p53 pathways both have pivotal roles in the
response to stress, where they participate in the immediate
molecular and cellular responses. They regulate common biolog-
ical processes to mitigate deleterious effects. Both pathways have
been studied in detail, but little is known about any crosstalk
between them, although in vitro studies suggested that USF1 may
regulate the basal transcription of the p53 gene [22,23]. We thus
examined whether USF1 could contribute to the canonical p53
stress response by directing proper cell fate decisions. We used a
combination of in vivo and in vitro genetic approaches to test for the
presence of a coordinated USF1/p53 program. We demonstrate
that in the presence of DNA damage, USF1 is necessary for
immediate p53 protein stabilization and that the p53-mediated
cell cycle arrest requires USF1. We report evidence that USF1 is
a central regulator of p53 to direct cell fate decisions, identi-
fying thereby a new functional and unexpected role for USF1.
Collectively, these findings have important and broad conse-
quences for our understanding of mechanisms that maintain stress-
induced DNA damage and cancer promotion.
Results
USF1-deficient mouse skin is unable to up-regulate p53
in presence of DNA damage
To identify a coordinated USF1/p53 program, we first
examined p53 expression (by assaying mRNA and protein levels)
and the p53 acute stress response in Usf1-/- mice. Mice were
challenged with UVB irradiation, a physiological inducer of direct
DNA-damage, known to activate the p53 pathway [24]. We
quantified Trp53 mRNA in skin cells from Usf1 KO mice and WT
littermates (n = 9 for each genotype) and found no significant
differences between the two genotypes both before and 5 hours
after UVB radiation (Figure 1A). Similarly, the basal level of the
p53 protein was low, with no statistical difference (Wilcoxon
Mann-Whitney test with W = 0,98) between the two genotypes
(n = 16 and n = 11 for respectively Usf1 KO mice and WT
littermates). However, while a significant and reproducible 2-fold
increase of the p53 protein was observed in WT littermates
5 hours post-UVB irradiation, p53 protein-levels remained low
and unchanged in Usf1-/- mice (Figure 1B). Phosphorylation of the
H2AX histone (cH2AX), a substrate of the DNAPK/ATM/ATR
axis [25,26], increased following irradiation in both genotypes
confirming comparable signal transmission of UVB-induced DNA
damage (Figure 1B). Levels of p53 remained low in Usf1-/-
mice compared to their WT littermates 12 h post-irradiation
(Figure S1A). This ruled out the possibility that the p53 response in
Usf1-/- mice was simply delayed. Following UVB-irradiation, the
p21, 14-3-3 sigma and PCNA genes were less strongly induced in
Usf1-/- than control mouse skin both in vivo (Usf1-/- mouse skin;
Figure 1C) and ex vivo (Usf1-/- cultured skin biopsies; Figure S1B).
Thus, the absence of induction of p53 in the Usf1-/- mice was
accompanied by weaker up-regulation of some p53 target genes
required for the DNA-damage response, 5 hours post-irradiation.
In addition, and in accordance with the use of the mice minimal
erythema dose (MED), Bax and Puma pro-apoptotic genes were not
up-regulated 5 hours post-irradiation in both genotypes (data not
shown).
Trp53-deficient mice have reduced DNA repair ability and
impaired cell cycle arrest in response to DNA-damaging agents
[27,28]. We therefore used immunohistochemistry (IHC) to
examine the effect of USF1 deficiency on these processes. Levels
of cyclobutane pyrimidine dimers (CPDs) in the epidermis and
dermis and in the bulge region, 5 hours post-irradiation, were
higher in Usf1-/- mice than WT littermates (Figure 1D). This
was confirmed by ELISA, which showed that there was twice as
much CPD in Usf1-/- mouse skin (5 h post-UV; n = 4, p,0.05)
(Figure 1E). We next examined the proliferation index of
epidermal cells by IHC using Ki-67, the cellular marker of cycling
cells [29]. In non UV-exposed skin, the proliferation index in
the inter-follicular areas was comparable in the two genotypes.
In response to UVB irradiation, however, the proliferation
index remained constant in Usf1-/- mice whereas it decreased by
approximately 50% in WT littermates (Figure 1, F and G). The
defect of DNA repair (Figure S1C and S1D) and the absence of cell
cycle control (Figure S1E) in reponse to UVB was also observed in
cultured skin biopsies of Usf1-/- mice, up to 24 h after irradiation.
Thus, in addition to defective induction of p53 protein upon UVB
exposure, Usf1 deficient cells fail to down-regulate their cell cycle
despite the presence of DNA damage.
USF1 is required for p53-dependent G1/S arrest upon
genotoxic stress
To decipher the specific contribution of USF1 and p53 proteins
to the regulation of cell cycle progression upon genotoxic stress, we
generated stable knock-down (KD) cell lines using the B16 mice
melanoma cells that express active p53 and USF1 pathways. The
effectiveness of the shRNAs used to knock down Usf1 and Trp53
was verified (Figure 2, A and B). Levels of Trp53 mRNA were
comparable in Usf1 KD and control cells (sh-CT) and remained
unchanged in response to UVB, whereas the levels of the p53
protein increased only in UVB-irradiated control cells (Figure 2, A
and B). The mRNA and protein levels of p21, the p53-dependent
effector of the G1/S arrest, remained low in both Usf1 KD and
Trp53 KD cells in response to UVB, whereas they increased in
control cells. Furthermore, consistent with findings for Usf1-/-
mice, time course experiments showed that there was no delayed
UV-induced p53 and p21 up-regulation in Usf1 and Trp53 KD
cells (Figure S3A). These findings showed that the KD cell culture
models reproduced features of Usf1-/- mice. To examine S phase
progression upon genotoxic stress, cells were synchronized and we
followed the synthesis of DNA by measuring the incorporation of a
thymidine analogue (BrdU). The results show that the proliferation
rates of synchronized Usf1 and Trp53 KD cells were similar to
that of control cells (Figure 2C). However, in the UVB-irradiated
Author Summary
Cancer is a complex disease that is characterized by the
sequential accumulation of genetic mutations. Exposure to
environmental agents, such as solar ultraviolet, induces
such alterations and thus contributes to the development
of genomic instability. The tumor suppressor p53 has a
central role in orchestrating cellular responses to geno-
toxic stress. In response to DNA-damage, p53 is stabilized
and activated to direct cell fate decisions. Cells in which
p53 stabilization is compromised become more vulnerable
to mutagenic agents and hence the mutation rate
increases, which promotes tumor development. Stabiliza-
tion of p53 is thus a critical step towards cancer
prevention. Using a genetic approach, we demonstrate
that the ubiquitous transcription factor Upstream Stimu-
latory factor 1 (USF1) is required for immediate p53
stabilization and appropriate cell fate decisions following
genotoxic stress. Furthermore, we show that this involves
a novel function of USF1 that underscores its critical role as
a stress sensor. The loss of USF1 expression should thus be
considered as a potential initiator of tumorigenesis in the
context of environmental insults.
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Figure 1. Usf1 KO mice present defective induction of p53 protein. The back of Usf1 KO mice (Usf1-/-) and WT mice (Usf1+/+) were irradiated or
not irradiated with an UVB dose corresponding to the mice MED (5 kJ/m2) and the skin was analyzed 5 h later. (A) RT-qPCR analysis of Trp53 and Usf1
mRNA relative level (expressed as a ratio to the value for the Hprt transcript) in skin extracts from protected (-) and UV-exposed (+) areas. Error bars:
SD, n.9. (B) Western blot showing USF1, p53, cH2AX and HSC70 (loading control) immunoreactivity 5 h after skin irradiated or not irradiated with
UVB. The graph reports the mean ratio between the p53 signal (normalized to that for HSC70) in skin-exposed areas versus non-irradiated areas
(controls). Error bars: SD, n = 8 for each condition. (C) Usf1+/+ (Usf1 WT) and Usf1-/- (Usf1 KO) skins were or were not irradiated with UVB (5 kJ/m2) and
analyzed for the induction of transcripts in vivo. RT-qPCR analysis of CDKN1a (p21), SFN (14-3-3s) and PCNA transcripts in UVB-irradiated skin and non-
exposed controls; values reported were normalized to those for the Hprt transcript. Transcripts were assayed in vivo 5 hours after irradiation. Error
bars: SD, n = 4 in vivo (D) Immunohistochemical labeling of cyclobutane pyrimidine dimers (CPD) showing their localization and abundance in skin
areas (x100) exposed or not exposed to UVB. Dashed lines indicate the boundary between the dermis (d) and the epidermis (e), and arrows indicate
positive nuclei. (E) The level of CPDs in total DNA extracts from skin was quantified by ELISA. The graph shows the mean difference in the CPD
absorbance values between for exposed and protected skin areas. Error bars: SD, n = 4. (F) Immunofluorescence staining with the Ki-67 antibody of
inter-follicular cycling cells in skin areas (x100) exposed or not exposed to UVB. (G) The graph shows the mean percentage of cycling cells (calculated
as Ki-67-positive cells/total Dapi-stained cells) in protected and UV-exposed skin areas. Error bars: SD, n = 3. Student’s t test was used to test the
significance of differences (*, p ,0.05, **, p,0.01, ***, p,0.001).
doi:10.1371/journal.pgen.1004309.g001
Figure 2. USF1 mediates p53-dependent cell cycle arrest. B16 melanoma cells knocked down for Usf1 (sh-Usf1) or p53 (sh-Trp53) and control
cells (sh-CT) were synchronized in G1/early S phase. The cells were then irradiated or not irradiated with UVB (0.3 kJ/m2) and the cell cycle released.
(A) Trp53, Usf-1 and p21 mRNAs in cells irradiated (+) or not irradiated (-) with UVB were quantified by RT-qPCR 3 hours after the release of the cell
cycle; results are reported relative to the values for the Hprt transcript. Error bars: SD, n = 3. (B) Western blot analysis of USF1, p53, p21 and HSC70
(loading control) in protein extracts from cells treated as in A. (C) BrdU incorporation assay in cells irradiated or not irradiated with UVB. The values
plotted are mean percentages of BrdU incorporating cells after UVB irradiation compared to those for non-irradiated cells. Error bars: SD, n = 3. (D)
Stripchart plot showing the volume of tumors formed 12 days after subcutaneous injections of 2.104 B16 melanoma cells (sh-Usf1, sh-Trp53 or sh-CT).
UVB (0.3 kJ/m2) irradiated or control cells, for which cell viability had been controled and was identical, were injected into the two sides of the back of
NOD/SCID mice. Error bars: SD, n = 4 for mice injected with sh-CT and sh-Trp53, and n = 5 for mice injected with sh-Usf1 cells. Student’s t test was used
for statistical analysis (*, p ,0.05, **, p,0.01, ***, p,0.001).
doi:10.1371/journal.pgen.1004309.g002
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condition, while the number of BrdU-incorporating cells remained
unchanged and comparable for the Usf1 and Trp53 KD cells,
irradiated control cells exhibited a significant reduction, of 50%,
in the number of BrdU-incorporating cells. Similar results were
obtained using primary fibroblasts isolated from Usf1-/- mice and
Usf1+/+ littermates (Figure S2). These data are consistent with
the in vivo results (Figure 1, F and G), highlighting a general
mechanism. In addition, USF1 levels did not differ between Trp53
KD cells and controls, indicating that USF1 expression is not
dependent on p53 (Figure 2, A and B). This also suggests that
the deficiency in cell cycle arrest of Usf1 KD cells in response to
genotoxic stress may be the result of the absence of increased levels
and/or activity of p53 and p21 [5,6,7,30,31].
The loss of p53 is a critical event that promotes tumor growth.
We therefore investigated whether loss of USF1 favors tumor
growth in vivo under stress conditions. To this end, we injected
NOD/SCID mice subcutaneously with mock- or UVB-irradiated,
viable Usf1 and Trp53 KD cells, and examined tumor growth 12
days later. The tumors produced by UVB-irradiated control cells
were half the size of those produced by mock-irradiated control
cells (Figure 2D). Usf1 and Trp53 KD cells both generated massive
tumors and their sizes were not modified by UV-pretreatment
(Figure 2D). This demonstrates that USF1, like p53, is required for
the transient cell cycle arrest in order to delay cell proliferation in
response to induced DNA damage.
USF1 is critical for p53 protein stabilization
We next investigated how USF1 controls p53 protein levels.
USF1 was re-expressed in Usf1 KD cells and we showed that
this restored the induction of p53 protein (Figure 3A) and p53
transcriptional activity in response to stress (Figure S3B). The
effects of re-expressing USF1 were independent of Trp53 transcript
levels (data not shown) and similar results were obtained with
USF1 mutants lacking the DNA binding domain as well as
the transcriptional activation domain (Figure S3C). These
observations suggest that USF1 positively regulates p53 protein
levels and activity independently of its transcription factor
function. Therefore, USF1 may act through translational and/or
post-translational mechanisms to modulate p53 availability.
Treatment of Usf1 KD and control cells with MG132 (an inhibitor
of proteasome activity) resulted in immediate and similar increases
of p53 protein levels in the two types of cell lines (Figure 3B). This
indicates that USF1 prevents the degradation of p53 rather than
inducing p53 synthesis. Furthermore, the abundance of USF1
protein in control cells remained unchanged when proteasome
activity was inhibited (Figure 3B), validating the use of the MG132
inhibitor as a powerfull in vitro tool to further investigate the
mechanism of p53 stabilization in the Usf1 KD background.
Phosphorylation of p53 is important for its stabilization and is
dependent on the activation of the DNA damage signal
transducers, DNAPK, ATM and ATR. Since the phosphorylation
of serine 15 (Ser15) in the p53 protein is required to mediate
interactions with other proteins to block contact with its inhibitor,
MDM2 [32,33], we specifically examined this modification. Usf1
KD and control cells were pre-treated with vehicle or MG132 to
stabilize the p53 protein and exposed to UVB. In the absence of
MG132 pre-treatment, UVB-induced phosphorylation of Ser15
and stabilization of p53 occurred only in control and not in Usf1
KD cells (Figure 3C). Inhibition of the proteasome degradation
pathway in the presence UVB resulted in comparable levels of
phosphorylated Ser15 and stabilization of p53 in Usf1 KD cells
and control cells (Figure 3D). These results, together with data
showing that phosporylation of Chk1, a downstream target of
the ATM/ATR pathway implicated in p53 activation [34], is
maintained in Usf1-/- mice (Figure S3D) and in the Usf1 KD cells
in response to UV (Figure S3E). This suggests that while upstream
mechanisms of transduction of the DNA-damage signal, targeting
p53-stabilization, are functional in Usf1 KD cells, the absence of
USF1 prevents full stabilization of p53.
We next examined whether USF1 modulates the half-life of
p53. Cells were pre-treated with MG132 (for 3 hours) to stabilize
p53, and time course experiments were performed with the
protein translation inhibitor, cycloheximide (CHX) (Figure 3E).
The half-life of the p53 protein in Usf1 KD cells was 30 min, and
in control cells was 110 min (sh-CT) (Figure 3F). To confirm these
results Usf1 KD and control cells were co-transfected with a vector
encoding a flag-tag p53 construct and a GFP control construct.
GFP was expressed at the same level in the two cell lines, but p53
levels in Usf1 KD cells were half that in control cells (Figure 3G).
These in vitro results together with work from the Levine group
[35,36] suggest that the steady state level of p53 depends on
the experimental systems used (ie cell tranfection, chemical
compound), which are known to challenge cells. We next
examined the half-life of p53 by irradiating cells before CHX
addition and our results show that the half-life of p53 was over
180 min in control cells but only 60 min in Usf1 KD cells (Figure
S4A). Together this supports a role for USF1 in modulating the
half-life of p53 under conditions of stress.
To examine whether impairment of p53 stabilization could
be associated with the binding of USF1 with p53, overexpressed
flag-tag p53 was immuno-precipitated from both Usf1 KD and
control cells transfected as above (Figure 3G) and treated with or
without MG132 and UVB. We observed an interaction of p53
with USF1 only in control cells and this interaction is notably
increased after UV irradiation when the p53 protein is stabilized
(Figure 3H, upper panel). In order to confirm this interaction
between p53 and USF1, we performed immunoprecipitations
assays with USF1 antibody in Usf1 KD and control cells, pre-
treated with MG132 and following exposure to UVB. Again, only
in the presence of USF1 was an interaction observed between
USF1 and p53 which was particularly evident after UV irradiation
(Figure 3H, lower panel). These results highlight the potential
function of the USF1 transcription factor in stabilizing the p53
protein through a direct interaction.
USF1 associates with p53 and inhibits MDM2-mediated
p53 degradation
Since stabilization of p53 in response to genotoxic-stress is
dependent on the regulation of its proteasomal degradation, we
measured the rate of p53-ubiquitination in the absence of USF1.
The basal level of ubiquitinated flag-tag p53 was approximately
three times higher in Usf1 KD than control cells (Figure 4A).
Following MG132 treatment there was a substantial accumulation
of ubiquitinated flag-tag p53 in Usf1 KD cells. Irradiation
following MG132 treatment had almost no effect on the levels
of ubiquitinated flag-tag p53 in Usf1 KD cells but this level was
almost half in control cells (Figure 4A). These investigations
demonstrate that USF1 interferes with the process of p53
ubiquitination and thereby maintains p53 stability following
exposure to genotoxic agents.
MDM2 is the E3-ubiquitin ligase that interacts with p53 to
promote p53 degradation by the proteasome and is therefore a
central regulator of p53 stability [8]. We thus examined whether
USF1 protects p53 from interacting with MDM2 and conse-
quently preventing its degradation, by using immunoprecipitation
assays performed with antibodies to MDM2 (Figure 4B). The anti-
MDM2 antibody precipitated p53 with MDM2 from Usf1 KD
cells but not from the control cells and UVB irradiation had no
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Figure 3. USF1 is required to stabilize p53 protein following genotoxic stress. B16 melanoma cells knocked down for Usf1 (sh-Usf1)
and their controls (sh-CT) were analyzed for post-translational regulation of p53. (A) Western blot analysis of the effect of USF1 re-expression on
p53 protein levels in sh-Usf1 cells irradiated or not irradiated with UVB and tested 6 h after irradiation. Cells were transfected with the cDNA indicated
USF1 Regulates p53 Protein Stability
PLOS Genetics | www.plosgenetics.org 6 May 2014 | Volume 10 | Issue 5 | e1004309
significant effect (Figure 4B). These results suggest that in the
absence of USF1, the interaction between p53 and MDM2 is
favored. These immunoprecipitation experiments showed that
USF1 and MDM2 did not interact with one another. Also,
MDM2 was similarly abundant in both control and knock down
cell lines under all conditions tested, indicating that silencing Usf1
did not interfere with MDM2 levels (Figure 4, B and C). In
addition, we demonstrate that the level of the MDM2 protein
remains unchanged under the cell culture conditions previously
tested (Figure S4 B–D). Together these results suggest that USF1
and MDM2 could bind p53 in a competitive manner.
To confirm that the interaction of MDM2 was responsible for
the increased degradation of p53 in Usf1 KD cells, we examined
the levels of flag-tag p53 in the presence of Nutlin-3, a specific
inhibitor of the MDM2-p53 interaction (Figure 4D). Consistent
with our previous results, the expression of flag-tag p53 in Usf1
KD cells was half that in control cells. A short treatment (6 h) with
Nutlin-3 almost completely restored the level of flag-tag p53 in
Usf1 KD cells. We next compared the ability of MDM2 to degrade
p53 in the presence and absence of USF1. Control and Usf1 KD
cells were transiently co-transfected with vectors expressing p53
and MDM2. Whereas co-expression with MDM2 led to a
decrease of approximately 70% of p53 protein in Usf1 KD cells,
there was only a 37% decrease in control cells (Figure 4E). When
we restored USF1 expression, the degradation of p53 mediated
by MDM2 was completly counteracted (Figure 4F). These results
provide further evidence that USF1 contributes to protecting p53
from MDM2-mediated degradation.
MDM2 has been reported to promote nuclear export of p53
and thereby targetting it for degradation [35]. We therefore
determined whether USF1 can interfere with MDM2 mediation of
p53 cellular localization under conditions described in Figure 4F
and using Nutlin-3. In the presence of Nutlin-3, the levels of p53
were exclusively nuclear and higher compared to control (vehicle).
When p53 and MDM2 were co-expressed, p53 was completely
degraded confirming the activity of MDM2 on p53. As expected,
the presence of Nutlin-3 almost completely counteracted the
MDM2-mediated degradation of p53 and led to accumulation of
p53 in the nucleus. Finally, similar to the results obtained for
Nutlin-3, co-expression of USF1 with p53 and MDM2 abolished
p53 degradation and maintained the nuclear localization of the
p53 protein (Figure 4G). Under comparable conditions of
overexpression, we quantified the interaction between p53 and
USF1 using the Duolink PLA techonology, and show that the
number of p53/USF1 interactions decreased when MDM2 was
co-expressed (Figure 4H). In addition, re-expression of USF1 (WT
or AUSF forms), with p53 and MDM2 led to a significant increase
of the number of p53/USF1 interactions (Figure 4H, right panel).
Together, these data demonstrate that USF1 interferes with
MDM2-mediated nuclear export of p53 and its subsequent
degradation by directly interacting with p53.
Discussion
Activation of the p53 pathway in response to DNA damage is a
critical mechanism that selectively directs cells to transient cell
cycle arrest to favor DNA repair or to promote cell death when
DNA damage is irreparable. Disruption of this protective pathway
leads to an increase in cells’ mutation load promoting genomic
instability and frequently cancer development [36]. Our study
demonstrates a new role for USF1 as a key upstream regulator of
the p53 pathway. We provide compelling evidence that USF1
binds to p53 under UV stress conditions, preventing MDM2-
mediated p53 degradation. Under stress conditions, USF1 thereby
ensures the stability and tumor suppressor activity of the p53
protein. We thus propose that USF1 directs appropriate p53-
dependent cell fate decisions in response to genotoxic stress
(Figure 5).
The transcription factors USF1 and p53 are both associated
with the stress response and with cell proliferation [37,38,39] and
while there is evidence suggesting a link between them, this had not
been demonstrated in vivo. For example, USF1 and p53 regulate
the transcription of common target genes including APC, BRCA2
and hTERT [18,40,41,42,43,44], and in vitro studies implicated
USF1 in the basal regulation of the Trp53 promoter [22,23]. Here,
we report that, in mice skin and in B16 melanoma cells, USF1
drives DNA damage-induced cell cycle arrest by regulating p53
protein stability and function. Thus in vivo loss of USF1 parallels
p53 deficency [27,45], with altered proliferation control in the
presence of DNA-damage. And like Trp53-/- [46,47] or p21-/- cells
[5], Usf1-/- primary fibroblasts bypass the transient cell cycle arrest
triggered by DNA damaging radiation. We further found that
under basal conditions the skin of WT and Usf1-/- mice contained
similar levels of p53 mRNA and protein, but observed differences
in p53 protein levels between the two genotypes after UVB
challenge. Despite previous suggestions, we could not demonstrate
a transcriptional link between USF1 and p53 [22,23]. This could
possibly be attributed to cell specificities or stress-dependent
contexts in which levels and activities of transcriptional factors,
required to drive Trp53 gene expression may vary [48]. Indeed, in
studies involving human skin and keratinocytes UV-induced p53
was shown to be regulated only at the post-translational level but
not at the mRNA level, while irritants that promote erythema
induced p53 mRNA expression [49,50]. These observations
indicate that USF1 may act through more than one route to
increase p53 levels according to cell type. In skin and in response
to UV-induced DNA damage USF1 controls the p53 protein
stability. This is expected to be of significant impact, since one
attractive strategy for cancer therapy is based on p53 reactivation
in cancers encoding normal but inactivated p53 protein, as
observed frequently in melanomas [51,52,53].
Our evidence that USF1 stabilizes the p53 protein suggests that
it may have functions independent of its well-defined role as a
transcriptional regulator. Indeed, USF1 regulates gene expression
(as described in the materials and methods) and analyzed for USF1, p53 and HSC70 (loading control). (B) Western blot showing USF1, p53 and
HSC70 immunoreactivity in sh-CT and sh-Usf1 cells at the indicated time following treatment with MG132 (10 mM). (C–D) Time course of
p53 accumulation and Ser15-phosphorylation in sh-CT and sh-Usf1 cells treated with vehicle (DMSO) in C or MG132 (10 mM) plus UVB
(0.3 kJ/m2) irradiation in D. (E–F) p53 degradation in sh-CT and sh-Usf1 cells pretreated for 3 h with MG132 (10 mM) and then with cycloheximide
(CHX 20 mM) (E). Cells were analyzed at the time points indicated after addition of CHX. The graphs show the results of densitometric analysis
of p53 immunoreactive bands (normalized to the loading controls H2AX or HSC70). (G) Western blot showing flag-tagged p53 and GFP proteins
in sh-CT or sh-Usf1 cells after co-transfection of the corresponding cDNA. (H, upper panel) Immunoprecipitation analysis to assay flag-tagged
p53 after transfection of sh-CT or sh-Usf1 with the corresponding cDNA. Cells were treated with MG132, were or were not irradiated with UVB
and analyzed 3 hours later. (H, lower panel) sh-CT and sh-Usf1 cells were treated with 10 mM MG132 for 3 hours then irradiated or not irradiated
with UVB. Western blot analysis of proteins immunoprecipitated from cell lysates with USF1 antibody and blotted with p53 (1C12) and USF1
antibodies.
doi:10.1371/journal.pgen.1004309.g003
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through binding E-box regulatory elements in the promoters
of target genes or by acting as a docking platform to recruit
chromatin-modifying enzymes such as CBP/p300, PCAF, Set7/9,
HDAC9 [54,55,56,57,58]. We now demonstrate that USF1
physically associates with the p53 complex. The ability of USF1
to promote p53 function appears to be independent from its ability
to bind DNA. We cannot however exclude the possibility that
the interaction between these two transcription factors may be
important to bring p53 in the vicinity of p53 DNA-responsive
element. Together this provides new prospects for how USF1
and p53 may regulate the expression of common target genes. In
addition, it shows that USF1 can function through a new and
unexpected mechanism to control cellular processes, broadening
the role of USF1 and of members of the b-HLH-LZ transcription
factors family.
Here we demonstrate that, in response to stress, USF1 associates
with p53 to ensure p53 function. USF1 thereby prevents MDM2-
mediated ubiquitination and subsequent degradation of p53. This
mechanism relies on a stress-dependent association of USF1 with
the p53 protein. Other stress-inducible transcription factors have
been reported to contribute to the regulation of p53. For example,
the transcription factor YY1 [59] enhances MDM2-mediated
ubiquitination of p53 while ATF3 [60] prevents p53 ubiquitina-
tion and TAFII31 [61] prevents MDM2 association with p53.
Although these transcription factors share a common role with
USF1 in mediating p53 stability, the function of USF1 is not
redundant since loss of USF, on its own, impedes p53 stabilization.
The importance of USF1 in regulating p53 function may first be
attributed to their hierarchical relation. Trp53 KD cells express
normal levels of USF1 but they are not able to direct cell cycle
arrest as observed for Usf1 KD cells. Similarly, overexpression of
USF1 in p53-null Saos2-cells is not able to mimic the effect of p53
on cell proliferation, while USF1 promotes p53 function in p53
expressing cells [62]. USF1 is thus proposed to operate as an
upstream regulator of p53 stability and function. Second, the
abundance of USF1 may also support its critical role in directing
p53 function. Indeed, while USF1 is constitutively expressed,
ATF3 and YY1 mediated p53-interaction requires their induction
in response to genotoxic stress [59,60]. This suggests that USF1
is an immediate regulator of p53 stabilization in response to
genotoxic stress. This however does not exclude the possibility that
these transcription factors could act sequentially. Why and how
the association of one factor with p53 is favored over another
remains however to be elucidated. One possibility could be that
the nature and intensity of the DNA damage regulate this to
influence p53-directed cell fate [13,63].
To date, the implication of USF1 in cancer development
has been investigated through only one angle, its function as a
transcription factor. SNPs affecting USF1 binding to the Pten
promoter have been found to be associated with Cowden
syndrome [64]; the loss of USF1 transcriptional activity has been
described in several breast cancer cell lines [65] and the activation
of the hTERT gene in oral tumors is associated with the decreased
expression of USF1 and USF2 [66]. Together, this supports the
transcriptional role of USF1 in cancer development, although
no association has been reported between mutations in the
USF1 coding sequence and UV-induced cancer or other cancers
Figure 4. USF1 counteracts MDM2-mediated p53 degradation upon cellular stress. p53 protein-protein interactions and MDM2 mediated
p53 degradation were studied in B16 melanoma cells knocked down for Usf1 (sh-Usf1) and their controls (sh-CT ). (A–B) sh-CT and sh-Usf1 cells were
treated with 10 mM MG132 for 3 hours then irradiated or not irradiated with UVB. Western blot analysis of proteins immunoprecipitated from cell
lysates (A) Immunoprecipitation analysis to assay ubiquitinated flag-tagged p53 after transfection of sh-CT or sh-Usf1 with the corresponding cDNA.
Cells were treated with MG132, were or were not irradiated with UVB and analyzed 3 hours later. The values reported indicate the level of p53
ubiquitination (normalized to the total amount of flag-tagged protein recovered). p53 expressing sh-Usf1 cells treated with MG132 has been arbitrary
chosen as the reference (100%) since it is the condition where normalized-level of p53-ubiquitinated protein is the highest. (B) sh-CT and sh-Usf1 cells
were treated with 10 mM MG132 for 3 hours then irradiated or not irradiated with UVB. Western blot analysis of proteins immunoprecipitated from
cell lysates with a mix of two MDM2 antibodies (SMP14 and 3G9) and blotted with p53 antibody (1C12). (C) Western blot analysis showing basal levels
of USF1, MDM2 and HSC70 (loading control) in sh-CT and sh-Usf1 cell lysates. (D) Western blot showing the effect of Nutlin-3 (10 mM, 6 h) treatment
on the levels of flag-tagged p53 and GFP proteins in sh-CT and sh-Usf1 cells; antibodies to USF1, p53, GFP and HSC70 (loading control) were used. (E)
Western blot analysis of p53, MDM2 and HSC70 (loading control) in sh-CT and sh-Usf1 cells over-expressing either p53 or p53 plus MDM2. (F) Same
experiment as in D but in sh-Usf1 KD cells over-expressing either GFP or USF1. (G) Immunofluorescence analysis of p53 expression and localization in
sh-Usf1 KD cells treated as in D and stimulated with vehicle (DMSO) or Nutlin-3 (10 mM) for 6 hours. Experiments have been done in triplicate and 15
to 20 microscopic fields analyzed per condition. (H) Quantification of the level of p53 and USF1 interaction in B16 melanoma cells using Thermo
Scientific Cellomics HCS Solution (fluorescent microscopy) using Duolink PLA technology. Quantification of p53-USF1 interaction level using specific
primary antibodies and Duolink PLA technology in B16 melanoma sh-CT cells over-expressing either p53 or p53 plus MDM2 (left panel). The graph
represents the cumulative level of fluorescence observed in B16 cells under specific spotted form. p53 plus GFP is used as control condition.
Quantification of p53-USF1 interaction level in B16 melanoma sh-Usf1 cells over-expressing p53 plus MDM2 and or not different forms of USF1 (wild
type or negative dominant (AUSF)) (right panel). p53 plus MDM2 is used as control condition.
doi:10.1371/journal.pgen.1004309.g004
Figure 5. Model of regulation of p53 stabilization by USF1 in
response to stress. USF1 prevents MDM2-mediated p53 degradation
under stress conditions, thereby ensuring the stability and tumor
suppressor activity of the p53 protein. Left Panel, in the absence of
stress, p53 is targeted to proteasomal degradation after binding to
MDM2, maintaining cell proliferation. Right Panel, under DNA-damage
context, USF1 counteracts MDM2 function by interacting with p53
thereby increasing its transcriptional activity to control transient cell
cycle arrest and DNA repair processes. In the absence of USF1, p53
stabilization is abolished abrogating cell cycle control in response to
DNA damage and thereby favoring genomic instability.
doi:10.1371/journal.pgen.1004309.g005
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[67,68,69]. Cancers are associated with exposure to environmental
and biological carcinogens, including virus infection, tobacco
smoke and sunlight, both of which promote DNA hypermethyla-
tion [70]. Interestingly, oncogenic transformation by Helicobacter
pylori infection is associated with the methylation of the USF1
promoter and subsequent inhibition of USF1 protein production
[71]. In addition, Helicobacter pylori infection has been also shown
to impair p53 protein stability [72]. It remains to be elucidated
whether this mechanism of stress-induced epigenetic transforma-
tion contributes to silencing of USF1 and thus impairing p53
stability and whether it is a new mechanism of how p53 loss of
function may occur in cancer cells.
In this work we demonstrate that USF1 is a critical stress sensor
required to direct appropriate p53-dependent cell fate decisions.
USF1 operates through a new and unexpected function revealing
additional functions for bHLH-LZ factors. Finally, our findings
suggest that the loss of USF1 expression should be consider as a




Usf1-/- (KO) and Usf1+/+ (WT) mice were kindly provided by
Sophie Vaulont (Cochin Institute) [73]. Animals 8–12 weeks old
were used for UV irradiation experiments. Mice were maintained
under specific pathogen-free (SPF) conditions in our accredited
animal facilities (A 35 – 238 – 40). For in vivo irradiation, the backs
of the mice were shaved, and one area was protected (non-exposed
control) and another irradiated (exposed area). For ex vivo analysis,
skin biopsies (0.8 cm diameter) were recovered from the back of
WT and Usf1-/- mice and maintained in culture as previously
described (Baron Y. et al., 2012). Skins were irradiated with a
single UVB dose (312 nm, 5 kJ/m2) using the Stratalinker
apparatus (Stratagene). This dose corresponds to the minimal
erythema dose (MED) of these mice, inducing erythema 24 h later.
Ethics statement
The present animal study follows the 3R legislation (Replace-
Reduce-Refine). It has been declared and approved by the French
Government Board (Nu5347). Animal welfare is a constant
priority: animals were thus sacrificed under anesthesia.
Cell culture, small hairpin (sh) RNA transductions, and
inhibitor treatments
Mice primary fibroblasts were isolated by collagenase dissoci-
ation of skin dermis from Usf1-/- and Usf1+/+ mice [74]. Cells were
cultured in DMEM (Invitrogen) medium containing 10% FBS and
1% penicillin-streptomycin at 37uC under a 5% CO2 atmosphere
for one week before the irradiation protocol. Cells were then
irradiated with 0.6 kJ/m2 UVB and harvested at the indicated
time points.
B16 mice melanoma cells were transduced with lentiviral
particles containing a vector carrying an shRNA (Sigma) targeting
the murine Usf1 mRNA (sh-Usf1 SHCLNV-NM_009480 clone
TRCN0000302005) or the Trp53 mRNA (sh-Trp53; SHCLNV-
NM_011640 clone TRCN000030210844), or carrying scrambled
shRNA (sh-CT (SHC002V). After infection, cells were maintained
under selection in the presence of puromycin (Invitrogen). Cells
were then routinely cultured in RPMI (Invitrogen) supplemented
with 10% FBS and 1% penicillin-streptomycin at 37uC under a
10% CO2 atmosphere. Cell were irradiated with 0.3 kJ/m
2 UVB
and harvested at the indicated time points. For MG132 assays,
cells were treated with 10 mM Z-Leu-Leu-al (Sigma) in RPMI
(Invitrogen) medium. For cycloheximide (CHX) treatment, after
3 h of MG132 treatment the culture medium was removed and
replaced by medium containing 20 mM CHX (Sigma). For Nutlin-
3 treatments, cells were stimulated with 10 mM of Nutlin-3 (Santa
cruz).
Cell cycle synchronization, cell viability and BrdU
incorporation analysis
B16 melanoma cells were synchronized in G1/S phase
following a double thymidine/aphidicolin block (16 h with
2 mM thymidine, released for 9 hours and then 16 h with 5 mg/
ml aphidicolin).Cell viability following exposure to UV was
measured using MTT test as previously described [21].
BrdU analysis was carried using an in situ BrdU detection kit
(BD Biosciences): as recommended by the manufacturer. Positively
stained cells (BrdU positives) and total cells (hematoxylin stained)
in 10 randomly selected microscopic fields (x100) were counted for
each condition.
Gene expression analysis
RNA extraction and RT-PCRq were as previously described
[21]. Relative amounts of transcripts were determined using
the delta Ct method. Data were normalized to the values for the
HPRT transcript. Forward (F) and reverse (R) primers were
designed using the Universal Probe Library Assay Design Center
(Roche) and their efficiency has been confirmed.
Western blotting and immunoprecipitation
Mouse skin proteins were extracted by pottering 8 mm diameter
skin biopsies in liquid nitrogen; the resulting powders were lysed in
a lysis buffer containing 10 mM EDTA, 50 mM pH 8 Tris-HCl,
0.5% Empigen BB, 1% SDS, 25 mM NaF, 1 mM orthovanadate,
25 mM b-glycerophosphate, and 1x protease inhibitor cocktail
(Roche Diagnostics). Cell culture protein lysates were obtained by
scraping off cells in NP40 lysis buffer: 20 mM Tris pH 7.5,
100 mM NaCl, 20 mM b-glycerophosphate, 5 mM MgCl2, 0.2%
NP-40, 10% glycerol, 1 mM NaF, 0.5 mM DTT, 1x protease
inhibitor cocktail. Equal amounts of protein (30 mg), quantified
using the BCA protein assay (Sigma) were denaturated in Laemmli
buffer for 5 min at 95uC and resolved by 15% SDS-PAGE.
Membranes were probed with appropriate antibodies and signals
detected using the LAS-3000 Imaging System (Fujifilm) were
quantified with ImageJ (http://rsbweb.nih.gov/ij/). The following
primary antibody were used: anti-USF1 (C:20), anti-HSC70 (B-6),
anti-MDM2 (SMP14), anti-GFP (Santa Cruz), anti-CPD (TDM2)
(MBL), anti-p53 (1C12), anti-phospho H2AX Ser139 (cH2AX)
(Cell Signaling), anti-total histone H2AX, anti-p21 (Abcam), and
anti-MDM2 (3G9) (Millipore) and anti-Ubiquitin (Dako).
Co-immuno-precipitation experiments were performed using
1 mg of protein with 2 mg of Rabbit IgG (Jackson ImmunoR-
esearch, West Grove, PA) as negative control or with 2 mg of
USF1 antibodies (C:20) or MDM2 antibodies (SMP14 and 3G9)
and incubated overnight at 4uC. Flag-tag proteins were immuno-
precipitated using the flag immunoprecipitation kit (Sigma).
Immunocomplexes were isolated using Protein A-G sepharose
beads.
Luciferase activity and transitory transfections
To analyze the transcriptional activity of p53, B16 melanoma
cells in 10 cm-diameter dishes were transiently transfected with
5 mg of pG13-Luc (carrying a p53-responsive element; [75]) alone
or in combination with 6 mg of pCMV GFP (encoding the GFP) or
pCMV-USF1 (WT, T153E, T153A, AUSF (negative dominant;
USF1 Regulates p53 Protein Stability
PLOS Genetics | www.plosgenetics.org 10 May 2014 | Volume 10 | Issue 5 | e1004309
[15]), or pCAG3.1 (encoding p53; [76]) and incubated for 24 h.
Cells were then passaged in 12-well plates and irradiated 24 h post
passage (a total of 48 h post transfection). Luciferase analysis was
conducted using the DUAL-Luciferase reporter assay kit accord-
ing to the manufacturer’s recommendations (Promega).
To study p53 degradation in the presence of MDM2 B16
melanoma cells in 6-well plates were transfected with 1 mg of a
plasmid encoding flag-tagged p53 protein (Flag-p53/pRK5;
Addgen, Plasmid 39237) alone or in combination with 2 mg of a
plasmid encoding the MDM2 protein (pCMV-myc3-HDM2;
Addgen, Plasmid 20935). For p53 stabilization rescue analysis in
sh-Usf1 KD cells, cells were co-transfected with 2 mg of plasmid
encoding GFP protein or USF1 wild type protein [15], together
with 1 mg of Flag-p53/pRK5 plus 2 mg of pCMV-myc3-HDM2.
The amount of plasmid DNA used for transfection was adjusted
with empty pCMV plasmid to be equal in every case.
CPD quantification by ELISA
CPD in skin tissues was assayed by ELISA, according to Cosmo
bio recommendations (Cosmo Bio Co., LTD., Japan). DNA was
purified with Nucleospin tissue extraction kits (Macherey-Nagel,
Düren, Germany). Briefly, 200 ng aliquots of denatured DNA were
distributed into 96-well plates precoated with protamine sulfate
(Polyvinylchloride flat-bottom). DNA lesions were detected with
specific mouse anti-CPD antibodies [21], and bound antibody was
revealed with a biotin/peroxidase-streptovidin system. The absor-
bance at 492 nm was used for quantitative measurements.
Immuno-histochemistry and immunofluorescence
staining
Skin biopsies were fixed in formalin (4%) and embedded in
paraffin. Paraffin-embedded tissu was cut into 4 mm-thick slices,
mounted on slides and dried at 58uC for 60 minutes. A Discovery
Automated IHC stainer and the Ventana DABMap detection kit
(Ventana Medical Systems) were used for immunohistochemical
staining. For DAB, detection slides were incubated with rabbit
monoclonal anti-CPD antibody (TDM, MBL) and bound antibody
was revealed with biotinylated goat anti-rabbit secondary antibody
(Vector laboratory, USA). Slides were then counterstained for 4
minutes with hematoxylin and rinsed. For fluorescence analysis,
slides were incubated with rabbit monoclonal Ki-67 (SP6,
bioscience leasanton CA) and bound antibody was detected
with secondary anti-rabbit FITC-conjugated antibody. Slides were
coverslipped in aqueous mounting medium containing DAPI.
The numbers of Ki-67-positive cells were evaluated by counting
the percentage of interfollicular-positive cells (Ki-67 among Dapi-
stained cells) in 10 different microscope fields (x40) per skin section.
For cyto-immunofluorecence staining, cells grown on coverslip
chambers were fixed with formalin (4%) for 20 min, washed with
PBS, quenched with 50 mM NH4Cl for 20 min and washed once
with PBS. The cells were permabilized with 0.1% Triton and
saturated with 1% PBS/BSA; 15 min later, the primary antibody
was added. Bound antibody was reveled with anti-rabbit Alexa
488 or anti-mouse FITC 588 secondary antibodies (Jackson).
Experiments have been done in triplicate and 15 to 20 microscopic
fields analyzed per condition. A minimum of one hundered cells
were analyzed per condition.
Detection of protein interactions with Duolink using PLA
technology (Sigma)
B16 melanoma were transiently or not transfected with
pCAG3.1 (encoding p53; [76]), pCMV-MDM2 (encoding
MDM2 protein), and pCMV-GFP (encoding the GFP protein)
or various pCMV-USF1 expressing vector (WT and AUSF forms;
[15]), and incubated for 24 h. Cells were then passaged in 96-well
plates and fixed using PFA 24 h post passage (a total of 48 h post
transfection). Protein-protein (USF1 and p53) or (p53 and MDM2)
interactions in B16 melanoma cells were then analyzed following
recommanded protocol by manufacturer (Sigma Aldrich) and
visualized in collaboration with the ImPACcell plateform (SFR
Biosit, University of Rennes, France) using Thermo Scientific
Cellomics HCS Solution. For quantification, a minimum of 15
microscopic fields were analyzed and the signal were counted in a
minimum of 60 cells. The following primary antibody were used:
rabbit anti-USF1 (C:20), mouse anti-MDM2 and mouse anti-p53
(1C12) or rabbit anti-p53 (Fl-393).
Supporting Information
Figure S1 Loss of USF1 alters skin CPD lesions removal and cell
proliferation after UVB irradiation of skin punch biopsies. (A)
Level of p53, in Usf1+/+ and Usf1-/- mice skin-exposed areas versus
non-irradiated areas (controls),12 hours post irradiation. Western
blot showing USF1, p53, cH2AX and HSC70 (loading control)
immunoreactivity 12 h after skin irradiated or not irradiated with
UVB. Graph reports the mean ratio between the p53 signal
(normalized to that for HSC70). Error bars: SD, n = 5 for each
condition. (B) Usf1+/+ (Usf1 WT) and Usf1-/- (Usf1 KO) cultured
skins explants were or were not irradiated with UVB (5 kJ/m2)
and analyzed for the induction of transcripts ex vivo. RT-qPCR
analysis of CDKN1a (p21), SFN (14-3-3s) and PCNA transcripts in
UVB-irradiated skin and non-exposed controls; values reported
were normalized to those for the Hprt transcript. Transcripts
were assayed in vivo 5 hours after irradiation. Error bars: SD, n = 3
ex vivo. (C) Detection of CPD DNA-damage by immunostaining
microscopy (x100) in skin punch biopsies from WT (Usf1+/+) (left
panel) or Usf1 KO mice (Usf1-/-) (right panel) before and after
irradiation (ranging from 3 to 24 hours) of skin with 5 kJ/m2 of
UVB. (D) Ex vivo analysis by ELISA quantification of CPD (using
specific anti-CPD antibody (CosmoBio LTD.)) kinetic of removal
(ranging from 3 to 24 hours) in WT and KO mice skin biopsies
treated with 5 kj/m2 UVB. Graph represents the mean of CPD
content in DNA extracted from exposed skin at different times, the
experiments was performed two times in duplicate. (E) Ex vivo
analysis of Ki-67 skin-interfolliclar staining in skin biopsies of WT
and KO mice dorsal skin treated with 5 kj/m2 UVB and harvested
after different times (ranging from 3 to 24 hours). Graph
representing the quantification of interfollicular Ki-67 stained
cells in UVB exposed skin cultures, data are expressed as
percentage of stained cells compared to non-exposed skin controls.
( JPG)
Figure S2 USF1 KO fibroblasts override S phase arrest following
genotoxic stress. Primary fibroblasts isolated from Usf1+/+ and
Usf1-/- mice were analyzed for S phase progression, and regulation
of p53 and p21 following UVB irradiation (0.6 k/jm2). (A) Graph
reporting the mean percentage of primary fibroblasts incorporating
BrdU after irradiation (0.6 k/jm2); values for non-irradiated
controls are given for reference. Error bars: SD, n = 3. (B) MTT
activity evaluation of primary fibroblast viability after UVB
irradiation compared to non-irradiated controls treated as in A.
Error bars: SD, n = 3. (C) Western blot analysis of p53 and p21 in
primary fibroblasts 6 hours after UVB irradiation. The graph
represents the densitometric evaluation of p21 and p53 bands
(normalized to those for HSC70). Error bars: SD, n = 3.
( JPG)
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to modulate p53 level and specific activity in response to UVB
irradiation (6 h after 0.3 kJ/m2). (A) Western blot analysis of p53,
p21 and HSC70 (loading control) proteins in sh-CT, sh-Usf1 and
sh-Trp53 cells following UVB irradiation. (B) p53 transcriptional
activity in sh-CT, sh-Usf1 and sh-Trp53 cells transfected with a
reporter plasmid encoding a p53 responsive element (p53-RE)
driving the luciferase gene and irradiated or not irradiated with
UVB. The graph reports luciferase activity following UVB
irradiation with the values for non-irradiated sh-CT cells used
for reference. Error bars: SD, n = 3. (C) Same experiment as in B
but with sh-Usf1 KD cells co-transfected with a reporter plasmid
encoding a p53 responsive element together with GFP or different
USF1 cDNA constructs. Schematic representation of the USF1
protein (with its DNA-Binding grey square, HLH light grey square
and LZ dark grey square domains) and various point mutations
modulating USF1 transcriptional activity: positively (T153E) or
negatively (T153A) and deletion form lacking DNA-binding
domain and transcriptional activity (AUSF). Error bars: SD,
n = 3. (D) Western blotting analysis of protein extracted of skin
from WT mice (Usf1+/+) and Usf1 KO mice (Usf1-/-) irradiated or
not irradiated with UVB (5 kJ/m2) analyzed 5 h later. (E) Western
blotting analysis of protein extracted from B16 melanoma cells
knocked down for Usf1 (sh-Usf1) or control cells (sh-CT) irradiated
or not irradiated with increasing doses of UVB (0 to 1.5 kJ/m2)
and analyzed 5 h later. Western blots show USF1, P-CHK1,
cH2AX, p53 and HSC70 (loading control) immunoreactivity after
or not UVB irradiation.
( JPG)
Figure S4 p53 and MDM2 stability in response to UV in
sh-Usf1 cells. (A) p53 degradation in sh-CT and sh-Usf1 cells
pretreated for 3 h with MG132 (10 mM) and then treated with
UVB previously to cycloheximide (CHX 20 mM). Cells were
analyzed at the time points indicated after UVB. The graphs
show the results of densitometric analysis of p53 immunoreactive
bands (normalized to the loading controls H2AX or HSC70). (B)
Western blot showing MDM2 and aTub immunoreactivity in B16
melanoma cells knocked down for Usf1 (sh-Usf1) or control cells
(sh-CT) cells at the indicated time following treatment with
MG132 (10 mM). (C-D) Time course of MDM2 accumulation in
sh-CT and sh-Usf1 cells treated with vehicle (DMSO) in C or
MG132 (10 mM) plus UVB (0.3 kJ/m2) irradiation in D. The
graphs show the results of densitometric analysis of MDM2
immunoreactive bands (normalized to the loading controls aTub).
( JPG)
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